Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Lithium plant developer zeros in on Thunder Bay refinery site

Ian Ross, Northern Ontario BusinessAvalon Advanced Materials making purchase offer on city property to start refinery construction by 2023The developer of a much-anticipated lithium processing...

Improved Recovery Rate Spurs Target Price Increase on Gold Developer

The metallurgical result and its implications are addressed in a ROTH Capital Partners report. In an Aug. 14 research note, ROTH Capital Partners analyst Jake Sekelsy reported that the final results from the metallurgical work done at Vista Gold Corp.'s (VGZ:...

Consolidating one of the largest advanced-stage, undeveloped gold projects in Canada

First Mining Gold Corp. a Canadian gold developer focused on the development and permitting of the Springpole Gold Project in northwestern Ontario, one of the largest undeveloped gold projects in...

Women's Wellness Device Developer Posts In-Line Quarter, Catalysts Looming

A review of this Colorado company's first numbers of the year was provided in a Ladenburg Thalmann report. In a May 13 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Viveve Medical Inc.'s (VIVE:NASDAQ) Q1/19 "reads fine." Q1/19 rev...

Bacteria Test Developer Reiterates Revenue Should Double in 2019

The product expected to drive that outcome is discussed in an H.C. Wainwright & Co. report. In a May 31 research note, analyst Ram Selvaraju reported that H.C. Wainwright & Co. lowered its target price on T2 BioSystems Inc. (TTOO:NASDAQ) to $10 per sha...

Coverage Initiated on Mining Triple Threat: Explorer, Developer, Producer

The basis of Haywood's investment thesis for this Canadian company is shared in a recent report. In a Nov. 28 research note, analyst Mick Carew reported that Haywood initiated coverage on K92 Mining Inc. (KNT:TSX.V) with a Buy rating and a CA$4.75 per share target p...

Antibody Developer Taken Out by Gilead at 'Hefty Premium'

The reasons Forty Seven attracted a buyer and its near-term catalysts are provided in a BTIG report. In a March 2 research note, BTIG analyst Robert Hazlett reported that Forty Seven Inc. (FTSV:NASDAQ) is being acquired by Gilead Sciences Inc. (GILD:NASDA...

Developer of Cannabinoid-Based Drugs to Resume Cancer Pain Trial

Calling this latest development "excellent news," Paradigm Capital has raised its target price on the company's stock. In an April 9 research note, analyst Rahul Sarugaser reported that Paradigm Capital raised its target price on Tetra Bio-Pharma Inc. (TBP:TSX.V; TBPMF...

Oncology Vaccine Developer's Lead Programs 'On Track or Better'

The biopharma's two assets are discussed and Q1/19 financial results are provided in a BTIG research report. In a May 13 research note, BTIG analyst Thomas Shrader reported that Gritstone Oncology Inc.'s (GRTS:NASDAQ) lead clinical programs, GRANITE and SL...

Gold Explorer and Developer 'On Track to Repeat Atlantic Gold Success'

Observations and takeaways from a visit to the company's Bulgaria properties are given in a Haywood report. In an Aug. 21 research note, Haywood analyst Mick Carew reported that Velocity Minerals Ltd. (VLC:TSX.V; VLCJF:OTCQB) is "is on track to repeat Atlantic Gold ...
1 2 3 4 5 6 7 8 9 10 ...